Drug interactions
Carboplatin + Sipuleucel-t
Severity: Moderate
Carboplatin and Sipuleucel-t: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Sipuleucel-T is an autologous cellular immunotherapy that depends on a functioning immune system. Myelosuppressive and immunosuppressive chemotherapy such as carboplatin may reduce the immune response to it and its efficacy. Labeling advises considering this before leukapheresis and infusion.
What this interaction means in plain words
Carboplatin and Sipuleucel-t can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Why it happens
Cytotoxic immunosuppression may impair the antigen-presenting cell activation and T-cell response that sipuleucel-T relies on.
What to do
Avoid giving chemotherapy around leukapheresis and infusion where possible. Weigh the benefit of each treatment and plan sequencing with the oncology team.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Carboplatin and Sipuleucel-t, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Carboplatin
Frequently asked questions
Can I take Carboplatin with Sipuleucel-t?
MediHelp rates the interaction as moderate. Carboplatin and Sipuleucel-t can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Sipuleucel-T is an autologous cellular immunotherapy that depends on a functioning immune system. Myelosuppressive and immunosuppressive chemotherapy such as carboplatin may reduce the immune response to it and its efficacy. Labeling advises considering this before leukapheresis and infusion.
How serious is the interaction between Carboplatin and Sipuleucel-t?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid giving chemotherapy around leukapheresis and infusion where possible. Weigh the benefit of each treatment and plan sequencing with the oncology team.
What other medicines interact with Carboplatin?
MediHelp also lists interactions of Carboplatin with, for example, Adenovirus types 4 and 7 live, Amikacin, Amphotericin b deoxycholate. The full list is on the Carboplatin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
